Table 3.
Outcome | Unadjusted odds ratio (95% CI) | Adjusted odds ratio (95% CI) |
---|---|---|
mRS 0–1 at 3 months | 0.928 (0.886–0.971) | 0.929 (0.877–0.985) |
mRS 0–2 at 3 months | 0.928 (0.892–0.965) | 0.933 (0.887–0.981) |
mRS 0–3 at 3 months | 0.951 (0.918–0.986) | 0.955 (0.911–1.000) |
Reperfusion at intervention (mTICI ⩾2B) | 0.945 (0.906–0.985) | 0.934 (0.885–0.984) |
mRS at 3 months (shift) | 1.046 (1.014–1.078) | 1.038 (1.001–1.077) |
Non-haemorrhagic worsening at 24 h | 1.053 (0.998–1.110) | 1.068 (0.996–1.144) |
Mortality at 3 months | 1.018 (0.979–1.058) | 0.988 (0.933 – 1.046) |
Symptomatic intracranial haemorrhage ECASS II definition | 1.008 (0.944–1.076) | 1.020 (0.927–1.123) |
ECASS II, European Co-operative Acute Stroke Study-II; mRS, modified Rankin Scale; mTICI, modified treatment in cerebral ischaemia.